Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.

ClinicalTrials.gov ID: NCT00753740

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00753740. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Multi-Center Randomized, Double-Blind, Placebo-Controlled Study of Maintenance IT-101 in Platinum Sensitive Ovarian Cancer Patients Who Received 4-6 Cycles of a 2nd Line Platinum-Based Regimen Without Disease Progression.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the effect of IT-101 on delaying cancer progression in patients with platinum sensitive ovarian cancer.

Study identification

NCT ID: NCT00753740
Recruitment status: Withdrawn
Study type: Interventional
Phase: Phase 2
Lead sponsor: NewLink Genetics Corporation; Industry
Enrollment: Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years to 78 Years
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 2008 (Type not available)
Primary completion: Oct 2009 (Actual)
Completion: May 2010 (Actual)
Last update posted: Jun 12, 2020

2008 – 2010

United States locations

U.S. sites: 7
U.S. states: 7
U.S. cities: 7

Facility	City	State	ZIP	Site status
Decatur Memorial Hospital, Clinical Research Department/ Cancer Care Specialists of Illinois	Decatur	Illinois	62526	—
University of Minnesota Medical Center	Minneapolis	Minnesota	55455	—
Schwartz Gynecologic Onclology, PLLC	Brightwaters	New York	11718	—
Gabrail Cancer Center	Canton	Ohio	44718	—
Chattanooga GYN Oncology	Chattanooga	Tennessee	97403	—
The Methodist Hospital	Houston	Texas	77030	—
Riverside Gynecology & Oncology	Newport News	Virginia	23601	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00753740, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 12, 2020 · Synced Nov 15, 2026